Notice

지속가능한 성장과 투명한 경영으로

신뢰를 만들어갑니다.

지속가능한 성장과 투명한 경영으로

신뢰를 만들어갑니다.

Notice

Research Review: Combating biofilms with microsystem devices

2025-01-13
조회수 146

University of Maryland, College Park, MD, USA

2021. 03. 19


A long-term, interdisciplinary research collaboration at the University of Maryland’s A. James Clark School of Engineering has made real progress in creating chemical compounds, developing new kinds of materials, and designing and building microsystems that can both detect and treat these infections.

Bacterial biofilms are almost always involved in device-associated and post-operative infections, and account for approximately half of all the estimated 700,000 to 2 million hospital infections annually. They form when planktonic bacteria adhere to moist surfaces and encase themselves in an extracellular matrix. This matrix offers significant protection for the bacteria against antimicrobial medicines, and also makes it easy for them to spread through gene transfer.

Biofilms easily form on implanted medical devices like catheters, prosthetic joints, and dental implants. Urinary catheters, some of the most commonly inserted medical devices, are susceptible to biofilm forming from bacteria in the urine at a rate of 5–7 percent per day. Because high doses of antibiotics are required for their removal, biofilms contribute to the increase in antibiotic-resistant strains of bacteria.

Doctors need far better ways to detect, measure and effectively treat biofilms.

“There is a need for non-invasive, real-time selective and sensitive detection of biofilms that can aid infectious disease practitioners in the treatment of biofilms on indwelling medical devices,” says Dr. Rodney Donlan of the Biofilm Laboratory at the Centers for Disease Control and Prevention in Atlanta.

In their 10-year collaboration, Professor Reza Ghodssi (Electrical and Computer Engineering; Institute for Systems Research), Professor William Bentley (Fischell Department of Bioengineering), and their students and colleagues have been advancing the state of the art in both biofilm detection and treatment. They have developed in-vitro microsystems that can detect and measure (“characterize”) biofilm, and in-vivo microsystems for biofilm treatment. The most recent device, which can be placed in urinary catheters, can do it all—detect, measure and treat biofilms.


자세히 보기 〉


b5f867c30b1ca.png

 

주식회사 프록시헬스케어  ㅣ  대표자 : 김영욱

울산광역시 울주군 청량읍 처용산업3길 135,

울산 자유무역지역 경공업2동 3층, 서편

대표전화  :  070-4124-8734

메일 : office@proxihealthcare.com

사업자번호 : 136-88-01475

개인정보보호책임자 : 김영욱

주식회사 프록시헬스케어  ㅣ  대표자 : 김영욱

울산광역시 울주군 청량읍 처용산업3길 135, 울산 자유무역지역 경공업2동 3층, 서편

대표전화  :  070-4124-8734 ㅣ 메일 : office@proxihealthcare.com

사업자번호 : 136-88-01475 ㅣ 개인정보보호책임자 : 김정교

COPYRIGHT ProxiHealthcare Inc. ALL RIGHTS RESERVED